Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome.
about
Patent ductus arteriosus ligation and adverse outcomes: causality or bias?Surgery and neurodevelopmental outcome of very low-birth-weight infantsPerinatal factors and regional brain volume abnormalities at term in a cohort of extremely low birth weight infantsPrediction of bronchopulmonary dysplasia by postnatal age in extremely premature infantsOccurrence and severity of bronchopulmonary dysplasia and respiratory distress syndrome after a preterm birth.Should we definitively abandon prophylaxis for patent ductus arteriosus in preterm new-borns?Does primary surgical closure of the patent ductus arteriosus in infants <1500 g or ≤32 weeks' gestation reduce the incidence of necrotizing enterocolitis?Prophylactic indomethacin and intestinal perforation in extremely low birth weight infants.High-Dose Oral Ibuprofen in Treatment of Patent Ductus Arteriosus in Full-Term NeonatesCurrent Status of Therapeutic Strategies for Patent Ductus Arteriosus in Very-Low-Birth-Weight Infants in Korea.The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasiaNonsteroidal anti-inflammatory administration and patent ductus arteriosus ligation, a survey of practice preferences at US children's hospitals.Serial echocardiography in very preterm infants: a pilot randomized trialPatent ductus arteriosus in preterm infants: do we have the right answers?Association of Antegrade Pulmonary Artery Diastolic Velocity with Spontaneous Closure of the Patent Ductus Arteriosus in Extremely Low-Birth-Weight Infants.Therapeutic closure of the ductus arteriosus: benefits and limitations.Patent ductus arteriosus in the preterm infant: to treat or not to treat?The history of ethical decision making in neonatal intensive care.Therapeutic strategies, including a high surgical ligation rate, for patent ductus arteriosus closure in extremely premature infants in a North American centre.Management of patent ductus arteriosus in preterm infants--where do we stand?Managing the patent ductus arteriosus: current treatment options.Predictors of bronchopulmonary dysplasia or death in premature infants with a patent ductus arteriosusEchocardiographic assessment of patent ductus arteriosus in very low birthweight infants over time: prospective observational study.Trends in Patent Ductus Arteriosus Diagnosis and Management for Very Low Birth Weight Infants.Morbidities associated with patent ductus arteriosus in preterm infants. Nationwide cohort study.Reflections of the changes in patent ductus arteriosus management during the last 10 years.Association of Patent Ductus Arteriosus Ligation With Death or Neurodevelopmental Impairment Among Extremely Preterm Infants.Lung Function and Bronchial Hyperresponsiveness in Adults Born Prematurely. A Cohort Study.Comparative Effectiveness of Nonsteroidal Anti-inflammatory Drug Treatment vs No Treatment for Patent Ductus Arteriosus in Preterm Infants.Surgical ligation of patent ductus arteriosus in premature infants: trends and practice variation.Antenatal corticosteroids: analytical decision model and economic analysis in a Brazilian cohort of preterm infants.Outcome of patent ductus arteriosus ligation in premature infants in the East of England: a prospective cohort study.Near-infrared spectroscopy for detection of a significant patent ductus arteriosus.The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment.Surgical Ligation Versus Percutaneous Closure of Patent Ductus Arteriosus in Very Low-Weight Preterm Infants: Which are the Real Benefits of the Percutaneous Approach?Percutaneous PDA Closure in Extremely Low Birth Weight Babies.Trends and variation in management and outcomes of very low-birth-weight infants with patent ductus arteriosus.What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants?Urinary NT-proBNP and ductal closure in preterm infants.Cerebral oxygenation during different treatment strategies for a patent ductus arteriosus.
P2860
Q33871314-05600A96-BE0C-4166-B28F-19230B26C96CQ34080691-E03F6C71-EB8D-4A06-89AD-63B81DC95B70Q34720825-D6F798B6-7237-41B4-80D6-E3960B7D04A7Q35107249-B8623399-BBA1-4134-A409-38CD25DE76BCQ35434097-01BF3910-A794-4E9E-B5DD-5F962C04D0B6Q35580251-619A7A17-3904-4168-B56D-C752719986CCQ35779724-2F8C5C56-5218-430E-8971-CCFB8DD476DDQ35943172-1996A045-741E-429D-AEB7-12143087830FQ36074887-4EDFD729-0AF5-4AB1-A124-A7EE766303F4Q36269441-27A97CAF-DCA9-4219-97FE-C2ACF2820129Q36768333-080CB7AE-8F91-4C24-ABC4-AEC074C2ADC8Q37324451-2D51A6E2-3CCA-4A23-A6C2-275DB9033E48Q37401617-58ECC283-ECC7-43B1-A4B9-F747E72FDBD8Q37451050-A2ECBA1C-1FAD-47DB-AB97-5DF8F608F7EBQ37628131-07BEAD6F-9C2F-499C-A9C0-0AAB865E3815Q37635171-40622AF8-19B5-448E-ADA1-F83534FB0C29Q37793846-72F6E2EC-5DE2-4AED-9D7A-DB944C9C6F44Q37878690-DC11A309-0BFE-4208-86F0-8E00389433B3Q38094688-BFED82B6-7598-47C1-A036-015E42F04277Q38152796-A2E0B583-F811-4DF4-9E05-CB043C3FAEB4Q38218037-04BBF2D0-4F9F-4E9B-895A-5CBB3738A9D5Q38380099-472DACC7-E66C-40BE-BF69-E94DE8E37CA0Q38407110-8A4D2D0F-CA2F-4BE5-B1BD-8351FB781CD0Q38676679-55BED18B-5456-4AB1-BD10-033E630458BDQ38708503-20CFD626-082D-4F83-A85D-5F57C1C7B27CQ38818767-C6161FD2-452C-40CD-B616-033A45ECA8EEQ40306212-FF7A077D-9541-493B-B512-89C349505712Q40368260-F5BDE69F-7B1B-4895-BC19-46E4EB86A422Q40398107-4556B239-B133-4093-80D9-59614B1F7996Q40513668-00116B60-096A-4FEA-B9B3-66E37483A682Q41172308-00BE6D76-937A-4265-B746-B0032DB3E67FQ45262484-24C1A509-494F-4D7D-B9CC-FFF5F2727F0EQ46129367-CB26BA25-B441-4434-9FC3-5162D5552267Q47134264-6384BD5D-C735-478F-A29E-F7CB5AB97054Q47177305-1446DA6D-FC72-4B65-ADBD-DC1ED6F77445Q47260017-1FCF575D-CC43-48F5-AA9B-616A254DC4FAQ47282381-566F6A7E-8E6B-4B1D-8BF7-EA3692944DBFQ47362615-933AF39F-2D78-4099-9102-1145F895A0A7Q48457621-3077F241-0ED2-4BC4-A00F-2BEC449A3D0FQ49131884-2D61E1DB-2064-4DD0-8D2F-7F564A7669AC
P2860
Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome.
@en
Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome.
@nl
type
label
Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome.
@en
Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome.
@nl
prefLabel
Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome.
@en
Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome.
@nl
P2093
P2860
P356
P1433
P1476
Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome.
@en
P2093
Douglas Kendrick
Ivan D Frantz
James I Hagadorn
Juliette C Madan
National Institute of Child Health and Human Development Neonatal Research Network
P2860
P304
P356
10.1542/PEDS.2007-2781
P407
P577
2009-02-01T00:00:00Z